For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

    FDC denies reports of stake sale

    |
     FDC denies reports of stake sale
    FDC: Quotes, News
    BSE 165.00BSE Quote0.3 (-0.18%)
    NSE 164.15NSE Quote2 (-1.22%)
    Pharma company, FDC strongly denied reports of a stake sale by the Chandavarkar family.
     

    "The Chandavarkar family which is promoters of pharma firm FDC, plan to sell their 67% stake in the company. Buyout fund Carlyle had shown interest in buying the company and had even valued it at about Rs3,800 crore. But it is not known if a transaction will take place with the private equity fund," a media reported had stated.

    "With reference to the news item appearing in a leading financial daily titled "Pharma Back on M&A Street, FDC Owners in Talks to Exit", FDC Ltd has clarified to BSE that the above news is completely false and baseless," FDC has clarified in statement to the exchange.

    The FDC stock was last traded at Rs 97 on the National Stock Exchange, after hitting a 52-week high of Rs 105 earlier in the day.

    GoodReturns.in

    Read more about: fdc
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

    Find IFSC

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more